skip to Main Content

News

Latest News, Announcements, and Press Releases

06Aug 20
Codexis Adds Dr. Jennifer L. Aaker To Its Board Of Directors

Codexis Adds Dr. Jennifer L. Aaker to its Board of Directors

REDWOOD CITY, Calif. , Aug. 06, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, announced the appointment of Jennifer L. Aaker , Ph.D. to its board of directors, expanding membership…
read more
01Aug 20
Codexis Reports Second Quarter 2020 Financial Results

Codexis Reports Second Quarter 2020 Financial Results

Revenues increased 21% to $15 million ; 72% rise in R&D revenue included a significant contribution from the Takeda biotherapeutics partnership Conference call with slides begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif. , Aug. 06, 2020 (GLOBE…
read more
27May 20

Codexis to Participate in Two Virtual Investment Conferences

REDWOOD CITY, Calif. , May 27, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will participate in two virtual investment conferences: 17 th Annual Craig-Hallum Institutional Investor Conference being held in a…
read more

Since 2002, Codexis has created new technologies to unlock the power of proteins®. Put our unmatched protein engineering expertise to work for you.

Unlock the power of proteins® with Codexis

Back To Top
Close search
Search